2013 Q2 Form 10-Q Financial Statement

#000117891313001366 Filed on May 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $100.0K $194.0K $230.0K
YoY Change -0.99% -15.65%
Cost Of Revenue $0.00 $6.000K $6.000K
YoY Change 0.0%
Gross Profit $90.00K $188.0K $224.0K
YoY Change -10.89% -16.07%
Gross Profit Margin 90.0% 96.91% 97.39%
Selling, General & Admin $1.390M $1.160M $1.920M
YoY Change -19.65% -39.58% 66.96%
% of Gross Profit 1544.44% 617.02% 857.14%
Research & Development $4.965M $3.421M
YoY Change 45.13% 59.49%
% of Gross Profit 2640.96% 1527.23%
Depreciation & Amortization $440.0K $310.0K $110.0K
YoY Change 238.46% 181.82% 37.5%
% of Gross Profit 488.89% 164.89% 49.11%
Operating Expenses $7.310M $4.965M $4.840M
YoY Change 79.52% 2.58% 79.33%
Operating Profit -$7.220M -$5.933M -$4.610M
YoY Change 81.82% 28.7% 70.8%
Interest Expense $230.0K $250.0K $440.0K
YoY Change -243.75% -43.18% 388.89%
% of Operating Profit
Other Income/Expense, Net $253.0K
YoY Change
Pretax Income -$6.990M -$5.680M -$4.170M
YoY Change 68.84% 36.21% 59.77%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.990M -$5.680M -$4.174M
YoY Change 69.04% 36.08% 59.74%
Net Earnings / Revenue -6990.0% -2927.84% -1814.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.20 -$0.97 -$0.94
COMMON SHARES
Basic Shares Outstanding 58.64M shares 58.33M 44.35M
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.90M $59.83M $39.54M
YoY Change 42.55% 51.32% -11.88%
Cash & Equivalents $9.007M $27.82M $11.61M
Short-Term Investments $44.89M $32.01M $27.94M
Other Short-Term Assets $599.0K $170.0K
YoY Change 56.4% -19.05%
Inventory
Prepaid Expenses $172.0K
Receivables $273.0K $1.740M
Other Receivables $0.00
Total Short-Term Assets $55.09M $61.11M $41.46M
YoY Change 44.23% 47.41% -9.13%
LONG-TERM ASSETS
Property, Plant & Equipment $11.87M $11.50M $3.066M
YoY Change 136.42% 275.11% 58.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $420.0K $790.0K $700.0K
YoY Change -67.44% 12.86% 288.89%
Other Assets $39.00K $113.0K $1.155M
YoY Change -90.22% 181.71%
Total Long-Term Assets $13.23M $13.23M $5.441M
YoY Change 43.38% 143.1% 115.06%
TOTAL ASSETS
Total Short-Term Assets $55.09M $61.11M $41.46M
Total Long-Term Assets $13.23M $13.23M $5.441M
Total Assets $68.32M $74.34M $46.90M
YoY Change 44.07% 58.51% -2.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.837M $2.577M $1.529M
YoY Change 107.38% 68.54% 19.45%
Accrued Expenses $1.040M $780.0K $230.0K
YoY Change 12.8% 239.13% 109.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.921M $5.765M $4.854M
YoY Change 7.23% 18.77% 154.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $680.0K $709.0K $4.140M
YoY Change -82.87% 728.0%
Total Long-Term Liabilities $4.929M $4.553M $4.141M
YoY Change 18.6% 9.95% 728.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.921M $5.765M $4.854M
Total Long-Term Liabilities $4.929M $4.553M $4.141M
Total Liabilities $10.85M $10.32M $8.995M
YoY Change 12.11% 14.71% 273.24%
SHAREHOLDERS EQUITY
Retained Earnings -$86.90M -$79.91M -$61.61M
YoY Change 32.18% 29.7%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.47M $64.02M $37.90M
YoY Change
Total Liabilities & Shareholders Equity $68.32M $74.34M $46.90M
YoY Change 44.07% 58.51% -2.6%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$6.990M -$5.680M -$4.174M
YoY Change 69.04% 36.08% 59.74%
Depreciation, Depletion And Amortization $440.0K $310.0K $110.0K
YoY Change 238.46% 181.82% 37.5%
Cash From Operating Activities -$5.020M -$4.980M -$2.520M
YoY Change 439.78% 97.62% 82.61%
INVESTING ACTIVITIES
Capital Expenditures $1.060M -$90.00K $310.0K
YoY Change 523.53% -129.03% 181.82%
Acquisitions
YoY Change
Other Investing Activities -$13.08M $9.150M $7.780M
YoY Change 861.76% 17.61%
Cash From Investing Activities -$14.14M $9.240M $7.450M
YoY Change 830.26% 24.03% -6872.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 330.0K 30.00K 0.000
YoY Change 43.48% -100.0%
NET CHANGE
Cash From Operating Activities -5.020M -4.980M -2.520M
Cash From Investing Activities -14.14M 9.240M 7.450M
Cash From Financing Activities 330.0K 30.00K 0.000
Net Change In Cash -18.83M 4.290M 4.930M
YoY Change 748.2% -12.98% -87.71%
FREE CASH FLOW
Cash From Operating Activities -$5.020M -$4.980M -$2.520M
Capital Expenditures $1.060M -$90.00K $310.0K
Free Cash Flow -$6.080M -$4.890M -$2.830M
YoY Change 452.73% 72.79% 89.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58638520 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
PLURISTEM THERAPEUTICS INC
psti Additional Shares Commited For Issuance
AdditionalSharesCommitedForIssuance
75 shares
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
169000 USD
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
-174000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Gain Aggregate
AvailableForSaleSecuritiesGrossUnrealizedGainAggregate
600000 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Aggregate
AvailableForSaleSecuritiesGrossUnrealizedGainAggregate
94000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Gain Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterFiveYearThroughTenYears
83000 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterFiveYearThroughTenYears
3000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Gain Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterOneYearThroughFiveYears
232000 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterOneYearThroughFiveYears
32000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Loss Aggregate
AvailableForSaleSecuritiesGrossUnrealizedLossAggregate
25000 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Aggregate
AvailableForSaleSecuritiesGrossUnrealizedLossAggregate
224000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Loss Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterFiveYearThroughTenYears
USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterFiveYearThroughTenYears
67000 USD
CY2013Q1 psti Available For Sale Securities Gross Unrealized Loss Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterOneYearThroughFiveYears
8000 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterOneYearThroughFiveYears
99000 USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
1679000 USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
383000 USD
CY2013Q1 psti Financial Income Expense Net
FinancialIncomeExpenseNet
253000 USD
CY2012Q1 psti Financial Income Expense Net
FinancialIncomeExpenseNet
436000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
842000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
401000 USD
psti Issuance Of Common Stock And Warrants Related To September2012 Public Offering
IssuanceOfCommonStockAndWarrantsRelatedToSeptember2012PublicOffering
34106000 USD
CY2012Q3 psti Limited Period Number Of Common Stock Options
LimitedPeriodNumberOfCommonStockOptions
1200000 shares
CY2012Q3 psti Limited Period Number Of Common Stock Options And Or Warrants Maximum
LimitedPeriodNumberOfCommonStockOptionsAndOrWarrantsMaximum
420000 shares
psti Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
-158000 USD
psti Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
-265000 USD
CY2013Q1 psti Other Long Term Assets
OtherLongTermAssets
49000 USD
CY2012Q2 psti Other Long Term Assets
OtherLongTermAssets
USD
CY2013Q1 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
3000 USD
CY2012Q1 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
511000 USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
1546000 USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
2432000 USD
CY2012Q3 psti Public Offering Number Of Shares Per Unit
PublicOfferingNumberOfSharesPerUnit
1 shares
CY2012Q3 psti Public Offering Number Of Shares To Be Purchased Per One Warrant
PublicOfferingNumberOfSharesToBePurchasedPerOneWarrant
0.35 pure
CY2012Q3 psti Public Offering Number Of Warrants Per Unit
PublicOfferingNumberOfWarrantsPerUnit
1 shares
CY2012Q3 psti Public Offering Purchase Price Per Unit
PublicOfferingPurchasePricePerUnit
4.00
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
1738000 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
100000 USD
CY2013Q1 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
4962000 USD
CY2012Q1 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
2910000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
11313000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6821000 USD
psti Sharebased Compensation Arrangement Warrants Exercised
SharebasedCompensationArrangementWarrantsExercised
718213 shares
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
2105000 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
3533000 USD
psti Stock Based Compensation To Contractor
StockBasedCompensationToContractor
1400000 USD
psti Stock Based Compensation To Contractor
StockBasedCompensationToContractor
1155000 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
2383000 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
4689000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2577000 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1368000 USD
CY2013Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1062000 USD
CY2012Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
877000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
922000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
575000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130000 USD
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
143356000 USD
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103619000 USD
CY2013Q1 us-gaap Assets
Assets
74337000 USD
CY2012Q2 us-gaap Assets
Assets
47420000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
61110000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
38192000 USD
CY2013Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
13227000 USD
CY2012Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
9228000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1130000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1283000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1213000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1219000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
4940000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
4246000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5164000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4179000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
8470000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
7153000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2400000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1624000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2668000 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1625000 USD
CY2013Q1 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
9045000 USD
CY2012Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
7023000 USD
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
285000 USD
CY2012Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
59000 USD
CY2013Q1 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
17000 USD
CY2012Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
58000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27821000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9389000 USD
us-gaap Cost Of Revenue
CostOfRevenue
18000 USD
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46448051 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
USD
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5469000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3987000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13460000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10607000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
6000 USD
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
6000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11605000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42829000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18432000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31224000 USD
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.00
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
446423 shares
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58674520 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46448051 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58674520 shares
us-gaap Cost Of Revenue
CostOfRevenue
18000 USD
CY2013Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
567000 USD
CY2012Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1576000 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779000 USD
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779000 USD
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2921000 USD
CY2012Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3505000 USD
CY2013Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
775000 USD
CY2012Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
522000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1159000 USD
CY2013Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
789000 USD
CY2012Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1287000 USD
us-gaap Depreciation
Depreciation
592000 USD
us-gaap Depreciation
Depreciation
312000 USD
CY2013Q1 us-gaap Derivative Asset Fair Value Net
DerivativeAssetFairValueNet
179000 USD
CY2012Q2 us-gaap Derivative Asset Fair Value Net
DerivativeAssetFairValueNet
-138000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1924000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4260000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4836000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
188000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
224000 USD
us-gaap Gross Profit
GrossProfit
566000 USD
us-gaap Gross Profit
GrossProfit
597000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
15000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
12000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
209000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
375000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1612000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-1009000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
1509000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-584000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4385000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
515000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1586000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
19000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
30000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
448000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-142000 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-498000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-1408000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-21627000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
278000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74337000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47420000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5765000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5522000 USD
CY2013Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4553000 USD
CY2012Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4156000 USD
CY2013Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
9045000 USD
CY2012Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7023000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-21000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35967000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
397000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5661000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29276000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11874000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2345000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-5680000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-4174000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14165000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10659000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5933000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4610000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15007000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11060000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
113000 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2400000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-2000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
21000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
213000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
187000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
684000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
52000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
709000 USD
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
USD
CY2012Q3 us-gaap Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
8000000 shares
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-489000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
526000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2694000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
2537000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
6566000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3247000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1313000 USD
CY2013Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
923000 USD
CY2012Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
651000 USD
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
18000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34106000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1861000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
397000 USD
CY2012Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
34106000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1030000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
750000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
12000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
6000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11501000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5019000 USD
CY2013Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1284000 USD
CY2012Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
383000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4965000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3421000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12859000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9253000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79912000 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65747000 USD
CY2013Q1 us-gaap Revenues
Revenues
194000 USD
CY2012Q1 us-gaap Revenues
Revenues
230000 USD
us-gaap Revenues
Revenues
584000 USD
us-gaap Revenues
Revenues
615000 USD
CY2013Q1 us-gaap Short Term Investments
ShortTermInvestments
22960000 USD
CY2012Q2 us-gaap Short Term Investments
ShortTermInvestments
21397000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
64019000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
37742000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
37901000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
43422000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
169000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000 USD
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58358476 shares
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44328201 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54507538 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43585104 shares

Files In Submission

Name View Source Status
0001178913-13-001366-index-headers.html Edgar Link pending
0001178913-13-001366-index.html Edgar Link pending
0001178913-13-001366.txt Edgar Link pending
0001178913-13-001366-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
psti-20130331.xml Edgar Link completed
psti-20130331.xsd Edgar Link pending
psti-20130331_cal.xml Edgar Link unprocessable
psti-20130331_def.xml Edgar Link unprocessable
psti-20130331_lab.xml Edgar Link unprocessable
psti-20130331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1313055.htm Edgar Link pending